An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients-Reference-Cited by-同舟云学术

An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients

Published:2008-10 Issue:10 Volume:3 Page:1096-1103
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kawada Ichiro,Soejima Kenzo,Watanabe Hideo,Nakachi Ichiro,Yasuda Hiroyuki,Naoki Katsuhiko,Kawamura Masafumi,Eguchi Keisuke,Kobayashi Koichi,Ishizaka Akitoshi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. American Cancer Society Cancer statistics, 2005;Jemal;Cancer J Clin,2005

2. Gefitinib. Current status in the treatment of non-small cell lung cancer;Tanovic;Drugs Today (Barc),2004

3. Targeted therapies for cancer 2004;Ross;Am J Clin Pathol,2004

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Nucleotide Polymorphisms (SNPs) Analysis of Resistant and Susceptible Sengon (Falcataria falcata) Accessions to Gall Rust Disease;IOP Conference Series: Earth and Environmental Science;2024-06-01

2. Molecular testing in lung cancer;Diagnostic Molecular Pathology;2024

3. Dual-probe ligation without PCR for fluorescent sandwich assay of EGFR nucleotide variants in magnetic gene capture platform;Microchimica Acta;2023-08-31

4. Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe;Molecular Diagnosis & Therapy;2021-12-14

5. Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer;Current Cancer Drug Targets;2019-09-06